MarketPeel
Insider Trading Intelligence
JM

James W. Mccollum

LENZ
DIRECTOR · LENZ THERAPEUTICS, INC. · CIK 0001200889
FILING MIX · LIFETIME100%/0%
BUYS
9
SELLS
0
TOTAL VALUE
$990.4K
COMPANIES
1
ACTIVE SINCE
Mar 2024
HOLDINGS NOW
22,100
AVG SELL PX
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by James W. Mccollum, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%+14.15%+0.95%+13.20%+13.20%
14d2+50.00%+12.71%-0.04%+12.75%+12.75%
30d2+100.00%+16.94%+2.91%+14.03%+14.03%
60d2+50.00%+2.77%+5.48%-2.71%-2.71%
90d2+50.00%+3.26%+1.85%+1.41%+1.41%
180d2+50.00%+31.29%+12.46%+18.82%+18.82%
1y2(1 pending)+100.00%+82.02%+14.09%+67.93%+67.93%
2y2(1 pending)+0.00%-49.40%+44.32%-93.72%-93.72%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
LENZ · 22,100 shares · as of Jun 15, 2026
0131,391262,783394,174525,56520252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 9 buys / 0 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
LENZ
LENZ THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,10022,100Jun 15, 2026Jun 15, 2026View →
LENZ
LENZ THERAPEUTICS, INC.
PURCHASE
10,500$22.79$239.3K10,500Nov 7, 2025Nov 10, 2025View →
LENZ
LENZ THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
13,50013,500Jun 11, 2025Jun 11, 2025View →
LENZ
LENZ THERAPEUTICS, INC.
PURCHASE
31,332$15.99$501.1K525,565May 13, 2024May 14, 2024View →
LENZ
LENZ THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
27,00027,000Mar 21, 2024Mar 25, 2024View →
LENZ
LENZ THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
6,5756,575Mar 21, 2024Mar 25, 2024View →
LENZ
LENZ THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
16,633$15.03$250.0K494,233Mar 21, 2024Mar 25, 2024View →
LENZ
LENZ THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
477,600477,600Mar 21, 2024Mar 25, 2024View →
LENZ
LENZ THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
95,03495,034Mar 21, 2024Mar 25, 2024View →
Other insiders · LENZ
Loading peer insiders…
About this filer
CIK 0001200889
ROLE
Director
PRIMARY
LENZ
COMPANIES
1
ACTIVE SINCE
Mar 2024
MARKETPEEL · /INSIDER/0001200889DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback